Please assess the completion status of the following clinical trial:

Trial Title: Provoked Craving Assessment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Current cigarette smokers who have smoked regularly, and smoke more than 20 cigarettes per day on a regular basis for at least a year;~* Good general health with (in the opinion of the investigator) no clinically significant and relevant abnormalities of medical history.~Exclusion Criteria:~* Any disease that may interfere with the absorption, metabolism or excretion of the study product.~* A medical condition that might jeopardise the safety of the subject or the validity of the study results. For example, recent myocardial infarction or cerebrovascular incident (within 12 weeks of the screening visit), phenylketonuria, unstable or worsening angina pectoris, Prinzmetals angina or severe cardiac arrhythmia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Nicotine Polacrilex mint mini lozenge (Type: ACTIVE_COMPARATOR): None
- placebo (Type: PLACEBO_COMPARATOR): mint mini lozenge with no active

Based on this trial design, predict the completion outcome and termination type (if applicable).